This study is designed to validate the performance of Masimo INVSENSOR00057 in detecting atrial fibrillation. The noninvasive ECG measurements will be compared to results obtained from an FDA-cleared ECG monitor.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
120
Noninvasive wearable health monitoring device
Masimo Corporation
Irvine, California, United States
Specificity of Masimo INVSENSOR00057 Atrial Fibrillation Detection Function
Specificity refers to the ability of Masimo INVSENSOR00057 to correctly identify individuals who do not have atrial fibrillation. High specificity is important in minimizing false positives.
Time frame: 1-5 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.